National Grand Rounds: AMSA Scorecard- The State of Medical School Conflict-of-Interest Policies and Cultivating a New Era of Change
Posted by March 25, 2013 at 12:00 PM
Join the National Physicians Alliance
and the American Medical Student Association
ON-LINE WEBCAST or LIVE IN-PERSON
National Grand Rounds:
The AMSA Scorecard: The State of Medical School Conflict-of-Interest Policies and Cultivating a New Era of Effective Change
Tuesday, April 9, 2013 from 12-1pm (EST)
>> Earn Free CME <<
Georgetown University Medical Center, Med-Dental Building, Room SW107,
3900 Reservoir Road, Washington, DC 20057
Reshma Ramachandran, Pharmfree Fellow, American Medical Student Association
Ms. Reshma Ramachandran is a rising fourth year medical student at Warren Alpert School of Medicine at Brown University. She is currently serving as the AMSA PharmFree Fellow, overseeing the PharmFree Campaign, which works with medical schools to ensure evidence-based rather than marketing-based medical education and empowers medical students to drive institutional change to mitigate conflicts of interest. She will be discussing the 2012-2013 results of the AMSA PharmFree Scorecard, a tool established in 2007 to grade medical schools on their conflict of interest policies. Now in its fifth iteration, the Scorecard encourages institutions to adopt strong and effective conflict of interest policies.
Daniel Carlat, MD, Director of the Pew Prescription Project
Dr. Daniel Carlat oversees the Pew Prescription Project, which seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care. He will provide an update on the rationale for upcoming changes to the 2014 AMSA Scorecard and offer institutions the opportunity to learn how best to prepare.
Click here to attend this live event in person.
Click here to register to participate in this event online via webast.
For more information please contact:
Ann Woloson, NPA Director of Education at email@example.com
Target Audience: Physicians, medical students, residents, fellows and other prescribers
• At the conclusion of the activity, participants will have learned how to identify the potential for and mitigate relationships with the industry create a conflicts of interest which may affect medical education, research and health care practice decisions.
• At the conclusion of the activity, participants will understand and employ best practices and utilize other tools available to medical professionals to avoid the potential and prevalence of academic-industry relationships to improve the quality of medical education and research at academic medical institutions and in patient care decision making.
Accreditation Statement: Medstar Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: Medstar Georgetown University Hospital designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent to their participation in the activity.
Acknowledgement: This event offered as part of the Partnership to Advance Conflict-free Medical Education. This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin.
Disclosures: Presentations will not include commercial products or services. Speaker Reshma Ramchandran has no financial relationships with commercial interests. Speaker Daniel Carlat disclosed he is the owner in absentia of Carlat Publishing, LLC (which publishes a continuing education newsletter in mental health), he has no involvement in management and has received no income since February of 2012.
This event offered as part of the Partnership to Advance Conflict-free Medical Education.
This partnership and related materials were made possible by a grant from the state
Attorney General Consumer and Prescriber Education Grant Program which is
funded by the multi-state settlement of consumer fraud claims regarding
the marketing of the prescription drug Neurontin.
Learn more at www.npalliance.org/conflict-free